2020 Tissue Regenerative Materials Market Report- Leading Players, Applications, Forecast to 2026

Press Release

ReportsnReports added a new report on The Tissue Regenerative Materials Market report delivers the clean elaborated structure of the Report comprising each and every business related information of the market at a global level. The complete range of information related to the Tissue Regenerative Materials Market is obtained through various sources and this obtained bulk of the information is arranged, processed, and represented by a group of specialists through the application of different methodological techniques and analytical tools such as SWOT analysis to generate a whole set of trade based study regarding the Tissue Regenerative Materials Market.

Download FREE PDF sample of this Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=2826482

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Tissue Regenerative Materials pipeline products.

Scope of this Report:
– Extensive coverage of the Tissue Regenerative Materials under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Tissue Regenerative Materials and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

Reasons to buy this report:
The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Tissue Regenerative Materials under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date.

Get FLAT 20% Discount on this Report @ https://www.reportsnreports.com/purchase.aspx?name=2826482

Table of Contents in this Report:
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Tissue Regenerative Materials Overview 6
3 Products under Development 7
3.1 Tissue Regenerative Materials – Pipeline Products by Stage of Development 7
3.2 Tissue Regenerative Materials – Pipeline Products by Territory 8
3.3 Tissue Regenerative Materials – Pipeline Products by Regulatory Path 9
3.4 Tissue Regenerative Materials – Pipeline Products by Estimated Approval Date 10
4 Tissue Regenerative Materials – Pipeline Products under Development by Companies 11
4.1 Tissue Regenerative Materials Companies – Pipeline Products by Stage of Development 11
4.2 Tissue Regenerative Materials – Pipeline Products by Stage of Development 12
5 Tissue Regenerative Materials Companies and Product Overview 13
5.1 Biora AB Company Overview 13
5.1.1 Biora AB Pipeline Products & Ongoing Clinical Trials Overview 13
5.2 Collagen Matrix Inc Company Overview 14
5.2.1 Collagen Matrix Inc Pipeline Products & Ongoing Clinical Trials Overview 14
5.3 Colorado Therapeutics, LLC Company Overview 16
5.3.1 Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 16
5.4 credentis AG Company Overview 17
5.4.1 credentis AG Pipeline Products & Ongoing Clinical Trials Overview 17
5.5 Gene Techno Science Co Ltd Company Overview 18
5.5.1 Gene Techno Science Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 18
6 Tissue Regenerative Materials- Recent Developments 31
6.1 Oct 22, 2019: CollPlant CEO Yehiel Tal appointed to serve on international society for Biofabrication’s Industry Relations Committee 31
6.2 Sep 26, 2019: CollPlant reports second quarter 2019 financial results and provides business update 31
6.3 Aug 29, 2019: Straumann Group announces two appointments to its Executive Management team 33
6.4 Aug 14, 2019: Straumann Group: Strong momentum continues as first-half organic revenue climbs 16% and core EBIT margin reaches 28% 34
6.5 Jun 20, 2019: Collplant announces corporate name change to Collplant Biotechnologies to better reflect its business 40
6.6 Jun 19, 2019: CelGro accelerates dental implant treatment 40
6.7 May 30, 2019: CollPlant reports first quarter 2019 financial results and provides business update 42
6.8 May 23, 2019: Full availability of Geistlich Fibro-Gide, the alternative soft-tissue graft 44
6.9 May 23, 2019: Credentis and DentaQuest Partner to Bring Innovative Cavity Prevention Products to US Markets 45
6.10 May 22, 2019: CollPlant Launches New HQ and R&D Center in Israel 46
6.11 May 16, 2019: CURODONT REPAIR is the superior treatment for white spots 46
6.12 May 01, 2019: Orthocell submits AUS regulatory application for CelGro 46
6.13 Apr 30, 2019: Promising start to the year with 17% organic growth in first quarter 47
6.14 Apr 11, 2019: CURODONT REPAIR FLUORIDE PLUS – distribution starts in the US 49
6.15 Apr 01, 2019: CollPlant Reports Fourth Quarter and Year End 2018 Financial Results and Provides Business Update 50
6.16 Feb 20, 2019: CURODONT PROTECT – Best Prophylaxis during Orthodontic Treatment 52
6.17 Feb 19, 2019: Straumann posts strong Q4, lifting full-year organic revenue growth to 19% as underlying EBITDA margin reaches 30% 52
6.18 Feb 04, 2019: CollPlant names Jonathan M.N. Rigby as Chairman of the Board 57
6.19 Jan 22, 2019: Straumann Group appoints Alastair Robertson as Head of Global People Management & Development 58
7 Appendix 59
7.1 Methodology 59
7.3 Contact Us 62
7.4 Disclaimer 62

and more..


Ganesh Pardeshi

Close